Intrahepatic Cholangiocarcinoma (Shanghai, Nat Commun 2014)

Summary

Intrahepatic Cholangiocarcinoma (Shanghai, Nat Commun 2014) is a study catalogued by cBioPortal DataHub under the cancer-type code ihch. EvidenceHelix groups it with liver, bile duct and gallbladder studies.

Study description

Whole exome sequencing of 103 tumor/normal sample pairs in 103 intrahepatic cholangiocarcinoma patients.

Text as published in the source's study metadata.

Citation & PubMed

Shanshan et al. Nat Commun 2014

Linked PubMed records: PMID 25526346

Source & licence

Metadata from cBioPortal DataHub at e1b75cd25b, available under the ODC Open Database License (ODbL) 1.0. See the Source metadata tab for every field.

Source metadata

Study identifier

ihch_smmu_2014

Short name

IHCH (Shanghai)

Source cancer-type code

ihch

Reference genome

not given

Source access groups

PUBLIC

Original study

View on cBioPortal

Metadata file

meta_study.txt at e1b75cd25b

Database licence

ODC Open Database License (ODbL) 1.0

Study-level metadata only (title, description, cancer-type code, citation, PubMed ids). No patient, sample, mutation or clinical data, and no publication full text, is included. Individual studies may carry their own terms; follow each study's source links before reusing its data.

Citations

Shanshan et al. Nat Commun 2014

• PubMed record 25526346 ↗

Citation counts are not part of the source metadata and are not shown.

Related studies

• Intrahepatic Cholangiocarcinoma (Mount Sinai 2015)

  Whole-exome sequencing of 8 tumor-normal paired iCCA samples by Liver Cancer Program at the Icahn School of Medicine at Mount Sinai, in collaboration with Barcelona-Clínic Liver Cancer Group.

  Liver, bile duct and gallbladderOther published and consortium studiesSource code ihchPubMed 1

• Intrahepatic Cholangiocarcinoma (MSK, Clin Cancer Res 2021)

  Targeted sequencing of IMPACT and CMO samples

  Liver, bile duct and gallbladderMSK studiesSource code ihchPubMed 1

• Intrahepatic Cholangiocarcinoma (MSK, Hepatology 2021)

  Targeted sequencing of 412 intrahepatic cholangiocarcinoma tumor/normal sample pairs.

  Liver, bile duct and gallbladderMSK studiesSource code ihchPubMed 1

• Ampullary Carcinoma (Baylor College of Medicine, Cell Reports 2016)

  Exome sequencing analysis of 160 cancers arising in the periampullary region, 62 of these clearly arising from either the bile duct (n = 44) or the duodenum (n = 18) and 98 for which the epithelium of origin could not…

  Liver, bile duct and gallbladderOther published and consortium studiesSource code ampcaPubMed 1

• Cholangiocarcinoma (ICGC, Cancer Discov 2017)

  Whole-exome sequencing and Targeted/Exome sequencing of 489 Cholangiocarcinoma samples from 10 countries.

  Liver, bile duct and gallbladderOther published and consortium studiesSource code cholPubMed 1

• Cholangiocarcinoma (National Cancer Centre of Singapore, Nat Genet 2013)

  Whole exome sequencing of 15 cholangiocarcinoma cases.

  Liver, bile duct and gallbladderOther published and consortium studiesSource code cholPubMed 1

• Cholangiocarcinoma (National University of Singapore, Nat Genet 2012)

  Exome Sequencing for Opisthorchis viverrini-related cholangiocarcinoma in 8 O.viverrini-related tumors and matched normal tissue.

  Liver, bile duct and gallbladderOther published and consortium studiesSource code cholPubMed 1

• Combined Hepatocellular and Intrahepatic Cholangiocarcinoma (Peking University, Cancer Cell 2019)

  Whole-exome sequencing of 121 combined hepatocellular and intrahepatic cholangiocarcinoma (cHCC-ICC) patients with matched normal pairs (whole-genome sequenced samples are not included here).

  Liver, bile duct and gallbladderOther published and consortium studiesSource code hccihchPubMed 1

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.